| Notch pathway: a journey from notching phenotypes to cancer immunotherapy G Monticone, L Miele Notch Signaling in Embryology and Cancer, 201-222, 2021 | 25 | 2021 |
| The efficacy of CB-103, a first-in-class transcriptional Notch inhibitor, in preclinical models of breast cancer M Vigolo, C Urech, S Lamy, G Monticone, J Zabaleta, F Hossain, ... Cancers 15 (15), 3957, 2023 | 9 | 2023 |
| Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses G Monticone, Z Huang, F Csibi, S Leit, D Ciccone, AS Champhekar, ... Frontiers in Immunology, 4895, 2022 | 9 | 2022 |
| Notch Signaling in Prevention And Therapy: Fighting Cancer with a Two-Sided Sword J Reichrath, S Reichrath Notch Signaling in Embryology and Cancer, 1-7, 2021 | 7 | 2021 |
| Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer F Hossain, DA Ucar, G Monticone, Y Ran, S Majumder, K Larter, H Luu, ... Frontiers in Immunology 14, 1244159, 2023 | 3 | 2023 |
| Minocycline-based metronomic therapy as a novel approach to enhance anti-tumor immune responses and reduce tumor burden in mouse models of colorectal cancer SV Ibba, HH Luu, M Ghonim, C Vittori, MJ Dean, G Monticone, F Peruzzi, ... Cancer Research 82 (12_Supplement), 4211-4211, 2022 | 2 | 2022 |
| Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2 G Monticone, Z Huang, P Hewins, T Cook, O Mirzalieva, B King, K Larter, ... EMBO reports, 1-27, 2024 | | 2024 |
| Targeting Cblb-Notch1 axis as a novel strategy for cancer immunotherapy G Monticone, F Csibi, S Leit, JE Austin, DA Ucar, FM Hossain, ... Cancer Research 82 (12_Supplement), 2064-2064, 2022 | | 2022 |
| Abstract P08: Adenosine-based cancer immunotherapy for COVID-19 G Monticone, A Ramsay, L Miele Clinical Cancer Research 27 (6_Supplement), P08-P08, 2021 | | 2021 |
| Delivering intra-tumoral immune modulators and targeting cancer stem cells using recombinant-AAVs DA Ucar, G Monticone, F Hossain, S Majumder, D Wyczechowska, ... Cancer Research 80 (16_Supplement), 6691-6691, 2020 | | 2020 |
| Investigating tumor infiltrating immune cells signature in obese triple negative breast cancer F Hossain, DA Ucar, M Sanchez-Pino, M Dean, S Majumder, ... Cancer Research 80 (16_Supplement), 3866-3866, 2020 | | 2020 |
| Targeting Notch1 via adenosine A2A receptor to modulate tumor immunity G Monticone, FM Hossain, DA Ucar, S Majumder, C Sorrentino, ... Cancer Research 80 (16_Supplement), 4517-4517, 2020 | | 2020 |
| Abstract P5-04-19: Sulindac sulfide as a non-immune suppressive gamma secretase modifier to target triple negative breast cancer F Hossain, DA Ucar, S Majumder, M Matossian, G Monticone, K Xu, ... Cancer Research 80 (4_Supplement), P5-04-19-P5-04-19, 2020 | | 2020 |
| Consequences of EGF-Module Mutations on Notch Signalling and Trafficking G Monticone PQDT-Global, 2019 | | 2019 |
| ‘Notch’wings to target cancer G Monticone, H Shimizu, M Baron European Journal of Cancer 1 (61), S170-S171, 2016 | | 2016 |
